Provided by Tiger Fintech (Singapore) Pte. Ltd.

Summit Therapeutics PLC

20.79
+1.608.34%
Post-market: 20.880.0881+0.42%19:59 EDT
Volume:3.23M
Turnover:66.24M
Market Cap:15.34B
PE:-67.06
High:21.30
Open:19.49
Low:19.20
Close:19.19
Loading ...

Sector Update: Health Care Stocks Gain Monday Afternoon

MT Newswires Live
·
25 Feb

Is Summit Therapeutics (SMMT) One of the Best Growth Stocks to Invest In According to Analysts?

Insider Monkey
·
25 Feb

BUZZ-U.S. STOCKS ON THE MOVE-BioMarin, Azul, Sun Communities

Reuters
·
24 Feb

Summit Therapeutics Shares Down as 4Q Loss Widens

Dow Jones
·
24 Feb

Stock Track | Summit Therapeutics Stock Plunges 5.02% on Monday Amid Clinical Trial Collaboration News

Stock Track
·
24 Feb

Summit Therapeutics Shares Reverse Course From Premarket Gains; Last Down 8.7%

THOMSON REUTERS
·
24 Feb

BUZZ-U.S. STOCKS ON THE MOVE- Twilio, Bath & Body Works, Wingstop

Reuters
·
24 Feb

Sector Update: Health Care Stocks Flat to Higher Pre-Bell Monday

MT Newswires Live
·
24 Feb

Exchange-Traded Funds, Equity Futures Higher Pre-Bell Monday as Investors Focus on Inflation Data

MT Newswires Live
·
24 Feb

BUZZ-U.S. STOCKS ON THE MOVE-Nike, Domino's Pizza, Apple

Reuters
·
24 Feb

Summit Therapeutics Partners With Pfizer to Test Cancer Drug Combinations

MT Newswires Live
·
24 Feb

BRIEF-Summit Therapeutics Collaborates With Pfizer To Evaluate Ivonescimab Trial

Reuters
·
24 Feb

Summit Therapeutics, Pfizer to Study Ivonescimab/ADC Combos

Dow Jones
·
24 Feb

BUZZ-Summit Therapeutics rises on clinical trial collaboration with Pfizer

Reuters
·
24 Feb

Summit Therapeutics Q4 Net Loss Widens, Yearly Cash Equivalents Rise -- Shares Up Pre-Bell

MT Newswires Live
·
24 Feb

Summit Therapeutics Shares up 10.2% Premarket After Collaboration With Pfizer for Cancer Drug Trial

THOMSON REUTERS
·
24 Feb